In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
AstraZeneca US granted FDA approval for ARIMIDEX
AstraZeneca files for licence extension
ISSI wins FDA approval for new breast cancer detection technology
AstraZeneca receives FDA approval for FASLODEX
FDA approves Atrix's prostate cancer product
Pharmacia & Upjohn receive FDA approval for Aromasin in breast cancer
FDA approves ZOMETA for bone complications of cancer
Cancer Charities Join Forces to Launch New Trial for Women with an Aggressive Type of Breast Cancer
Competitive Technologies licensee begins breast cancer trial
Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
